Literature DB >> 25646018

Protective role of cyclosporine A and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin.

Na Guan1, Ya-Li Ren2, Xiao-Ya Liu1, Ying Zhang3, Pei Pei3, Sai-Nan Zhu4, Qingfeng Fan5.   

Abstract

BACKGROUND: Dysfunction of mitochondria is involved in podocyte injury in some kidney diseases, but the relationship between abnormal mitochondrial morphology and podocyte injury as well as the underlying mechanism is still unclear. This study aims to investigate dynamic changes of mitochondrial morphology and the potential molecular events in an adriamycin (ADR)-induced podocyte injury model.
METHODS: Podocyte apoptosis was evaluated by annexin V assay. Podocyte mitochondrial membrane potential (MMP) was measured with MitoCapture kit. Double staining was used to show the distribution changes of mitochondria and actin filament as well as mitofusin proteins and podocin. Mitochondrial shape descriptors were obtained using analySIS Image system. Effects of cyclosporine A (CsA) or minocycline (Mcy) on mitochondrial morphology were explored in ADR-induced nephropathy rats.
RESULTS: ADR caused podocyte damage displaying as induction of cellular apoptosis and increase of activated caspase 3 and cytochrome c. The MMP level was decreased remarkably in ADR-treated podocytes. Mitochondrial morphological changes induced by ADR occurred rapidly from large and ellipsoid shape to the small, long and irregular. ADR significantly decreased surface area, perimeter and circularity, while increasing aspect ratio of mitochondria. In addition, mitochondria number transiently increased at 6 h following ADR application. Mitochondria intensity was increased along with punctate mitochondria formation, which co-localized with polymerized actin cytoskeleton in ADR podocytes. In ADR-induced nephropathy rats, 24-h proteinuria was decreased significantly by CsA or Mcy. ADR-induced abnormal changes of mitochondrial morphology were restored by CsA or Mcy. The induction of mitofusin proteins and the reduction of podocin in ADR rat glomeruli were rescued by CsA or Mcy.
CONCLUSIONS: Mitochondrial dysfunction may be an early event in ADR-induced podocyte damage, and the protective role of CsA or Mcy may be mediated partially by improving mitochondrial function through inhibiting the induction of mitofusin proteins.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  cyclosporine A; minocycline; mitochondria; mitofusin; podocyte

Mesh:

Substances:

Year:  2015        PMID: 25646018     DOI: 10.1093/ndt/gfv015

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

1.  Knocking down Cabin1 induces glomerular podocyte injury.

Authors:  Yueqiang Wen; Lingling Liu; Qingdong Xu; Peilan Zhou; Huiyuan Li; Zebin Wang; Jianbo Liang
Journal:  Int Urol Nephrol       Date:  2018-01-24       Impact factor: 2.370

Review 2.  Mitochondria Damage and Kidney Disease.

Authors:  Pu Duann; Pei-Hui Lin
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.

Authors:  Xiujin Shen; Hong Jiang; Meike Ying; Zhoutao Xie; Xiayu Li; Haibing Wang; Jie Zhao; Chuan Lin; Yucheng Wang; Shi Feng; Jia Shen; Chunhua Weng; Weiqiang Lin; Huiping Wang; Qin Zhou; Yan Bi; Meng Li; Lingyan Wang; Tongyu Zhu; Xiaoru Huang; Hui-Yao Lan; Jing Zhou; Jianghua Chen
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

4.  Therapeutic efficacy of cyclosporin A against spinal cord injury in rats with hyperglycemia.

Authors:  Zhi-Rong Chen; Yi Ma; Hao-Hui Guo; Zhi-Dong Lu; Qun-Hua Jin
Journal:  Mol Med Rep       Date:  2018-01-11       Impact factor: 2.952

5.  Hyperoside alleviates adriamycin-induced podocyte injury via inhibiting mitochondrial fission.

Authors:  Zhuyun Chen; Xiaofei An; Xi Liu; Jia Qi; Dafa Ding; Min Zhao; Suyan Duan; Zhimin Huang; Chengning Zhang; Lin Wu; Bo Zhang; Aihua Zhang; Yanggang Yuan; Changying Xing
Journal:  Oncotarget       Date:  2017-09-28

Review 6.  How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy?

Authors:  Zhendong Feng; Wenbin Liu; Han Xue Jiang; Haoran Dai; Chang Gao; Zhaocheng Dong; Yu Gao; Fei Liu; Zihan Zhang; Qihan Zhao; Lei Zhang; Baoli Liu
Journal:  Front Pharmacol       Date:  2020-07-03       Impact factor: 5.810

7.  Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment.

Authors:  Tomoaki Higuchi; Kae Takagi; Akiko Tochimoto; Yuki Ichimura; Takanari Norose; Yasuhiro Katsumata; Ikuko Masuda; Hisashi Yamanaka; Toshiro Morohoshi; Yasushi Kawaguchi
Journal:  Arthritis Res Ther       Date:  2019-04-18       Impact factor: 5.156

8.  The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis.

Authors:  Yi Chen; Liyu Lin; Xuan Tao; Yankun Song; Jiong Cui; Jianxin Wan
Journal:  BMC Nephrol       Date:  2019-03-28       Impact factor: 2.388

9.  IP3R-Grp75-VDAC1-MCU calcium regulation axis antagonists protect podocytes from apoptosis and decrease proteinuria in an Adriamycin nephropathy rat model.

Authors:  Han Xu; Na Guan; Ya-Li Ren; Qi-Jiao Wei; Ying-Hong Tao; Guo-Sheng Yang; Xiao-Ya Liu; Ding-Fang Bu; Ying Zhang; Sai-Nan Zhu
Journal:  BMC Nephrol       Date:  2018-06-15       Impact factor: 2.388

10.  Efficacy of a mitochondrion-targeting agent for reducing the level of urinary protein in rats with puromycin aminonucleoside-induced minimal-change nephrotic syndrome.

Authors:  Yuko Fujii; Hideki Matsumura; Satoshi Yamazaki; Akihiko Shirasu; Hyogo Nakakura; Tohru Ogihara; Akira Ashida
Journal:  PLoS One       Date:  2020-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.